First Allied Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

First Allied Advisory Services’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$234K	Buy	+454	New	+$230K	0.01%	1005

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

First Allied Advisory Services's BIO Position: Q3 2020 in Review

First Allied Advisory Services opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2020: 454 shares worth $234K. The stake represents 0.01% of the portfolio and ranks #1005 among its holdings.

478 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

First Allied Advisory Services held 454 shares of Bio-Rad Laboratories Class A worth $234K as of Q3 2020.
Bio-Rad Laboratories Class A was a new First Allied Advisory Services position in Q3 2020.
Bio-Rad Laboratories Class A made up 0.01% of First Allied Advisory Services's portfolio in Q3 2020, its #1005 holding.
478 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.